The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Varian Medical Systems
Consulting or Advisory Role - Abbvie
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems
CCTG BL13 a randomized phase II trial assessing trimodality therapy with or without adjuvant durvalumab to treat patients with muscle-invasive bladder cancer (NCT03768570).
 
Wassim Kassouf
Consulting or Advisory Role - BMS; Ferring; Janssen; Merck; Roche; Sesen Bio
Research Funding - Roche (Inst); Sesen Bio (Inst)
 
Simon J. Crabb
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; EMD Serono; MSD; Novartis; Pfizer; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Roche
Expert Testimony - Merck/Pfizer; MSD
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen
 
Ignacio Duran
Honoraria - Astellas Pharma; Bayer/Onyx; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Immunomedics; Janssen Oncology; MSD Oncology; Novartis; Pfizer/EMD Serono; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Ipsen; Pfizer/EMD Serono; Roche/Genentech
 
Michael Donald Brundage
Research Funding - Pfizer
 
M. Neil Reaume
Honoraria - AstraZeneca; EMD serono; Ipsen; Novartis; Pfizer
Research Funding - AstraZeneca
 
Alice Dragomir
No Relationships to Disclose
 
Alexander William Wyatt
Honoraria - Astellas Pharma; AstraZeneca; AstraZeneca Canada; Janssen; Merck
Consulting or Advisory Role - AstraZeneca
Research Funding - ESSA (Inst)
 
Francisco Emilio Vera Badillo
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen Oncology
Research Funding - AstraZeneca/MedImmune (Inst)
 
Himu Lukka
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen; Sanofi; TerSera
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen; Sanofi; TerSera
Speakers' Bureau - Abbvie; Astellas Pharma; Bayer; Janssen; Sanofi; TerSera
 
Tamim Niazi
Stock and Other Ownership Interests - Knight Pharmaceuticals
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Sanofi; Tersera
Consulting or Advisory Role - Abbvie; AstraZeneca Canada; Bayer; Janssen Oncology; Sanofi; Tersera
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi; Tersera
 
Luis Souhami
No Relationships to Disclose
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)
 
Gareth Owen Griffiths
Honoraria - AstraZeneca Canada
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca Canada (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); HeartFlow (Inst); Janssen-Cilag (Inst); Novartis (Inst); Roche (Inst)
 
Doris Howell
Employment - Carevive
Leadership - Carevive
Consulting or Advisory Role - Carevive
 
Harriet Richardson
No Relationships to Disclose
 
Marina Djurfeldt
No Relationships to Disclose
 
Keyue Ding
No Relationships to Disclose
 
Wendy R. Parulekar
No Relationships to Disclose